PRPOライブシグナル | Getagraph.comで利益を最大化

Live Chart Being Loaded With Signals

Commentary (27 4月 2024 @ 05:00):

Precipio, Inc., a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services...

Stats
本日の出来高	37.00
平均出来高	5 282.00
時価総額	8.24M
EPS	$0 ( 2024-04-04 )
次の収益日	( $-0.930 ) 2024-05-15
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-1.330
ATR14	$0 (0.00%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-15	Laporte Kathleen	Buy	9 693	Common Stock
2024-04-15	Sandberg Richard A	Buy	5 913	Common Stock
2024-04-15	Cossman Jeffrey	Buy	8 143	Common Stock
2024-04-15	Cohen David Seth	Buy	3 575	Common Stock
2024-04-15	Andrews Ronald Asbury	Buy	3 153	Common Stock

INSIDER POWER
99.41
Last 96 transactions
Buy: 2 731 117 \| Sell: 221 280

Precipio Inc 相関

10 最も正の相関
SLGC	0.874
VUZI	0.835
SIFY	0.833
MOGO	0.829
TCON	0.821
SBGI	0.811
ISPC	0.807
STAA	0.802
PCT	0.801

10 最も負の相関
BNIXU	-0.894

知っていましたか？

相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関（1つの変数が増加すると、もう一方は減少する）、1は完全な正の相関（1つの変数が増加すると、もう一方も増加する）、0は相関がないことを示します（変数間に関係がない）。

相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。

Precipio Inc 財務諸表

Annual	2023
収益:	$15.20M
総利益:	$4.50M (29.62 %)
EPS:	$-4.51

FY	2023
収益:	$15.20M
総利益:	$4.50M (29.62 %)
EPS:	$-4.51

FY	2022
収益:	$9.41M
総利益:	$2.51M (26.67 %)
EPS:	$-10.73

FY	2021
収益:	$8.85M
総利益:	$2.39M (27.03 %)
EPS:	$-0.400

Financial Reports:

No articles found.

Precipio Inc

Precipio, Inc., a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; HemeScreen, a suite of robust genetic diagnostic panels; ICE-COLD PCR, a proprietary and patented specimen technology that increases the sensitivity of molecular based tests; and COVID-19 antibody tests. It sells ICE-COLD-PCR technology kits to bio-pharma customers. Precipio, Inc. has collaborations with academic institutions specializing in cancer research, diagnostics, and treatment. The company is based in New Haven, Connecticut.